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Programmed changes in genomic structure are essential
to development of the immune system. The antigen re-
ceptors of mature B and T lymphocytes are produced
by a site-specific recombination process that rearranges
V, D, and J gene segments into the V(D)J regions en-
coding the variable domains. Later, after activation of a
mature B cell by its specific antigen, gene structure and
variable region sequence undergo further alteration.
Class switch recombination joins a new constant (C)
region to an expressed variable (V[D]J) domain, to allow
efficient removal of antigen from the body. Somatic hy-
permutation introduces single base changes into the var-
iable regions of immunoglobulin genes and then is cou-
pled with selection, which results in an increase in
antibody affinity for antigen.
Here, I provide a brief overview of three processes
that create and fine-tune immunoglobulin genes as the
immune system develops and responds to foreign anti-
gens: V(D)J recombination, class switch recombination,
and somatic hypermutation. I then discuss class switch
recombination in greater detail, focusing on recent re-
sults that show that class switch recombination depends
significantly on genes essential in other contexts.
Because development of the immune system relies on
recombination, one might predict that genes that func-
tion in recombination and/or repair in the immune sys-
tem would be identified as genes that, when mutated,
cause immundeficiency diseases. It is therefore not sur-
prising that several immunodeficiencies have been cor-
related with deficiencies in enzymes essential to recom-
bination/repair. For example, Omenn syndrome is a
combined B and T cell immunodeficiency that, just in
the last year, was shown to result from mutations in
RAG1 or RAG2, whose products carry out the cleavage
step in V(D)J recombination (Villa et al. 1998). Severe
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combined immunodeficiency (scid) mutant mice provide
another example, as they almost completely lack mature
B cells and T cells because of mutation in the gene that
encodes the catalytic subunit of DNA protein kinase
(DNA-PKcs), an essential component of the nonhomo-
logous end-joining pathway for repair of double-strand
breaks (Petrini 1999 [in this issue]). As discussed below,
this repair pathway processes the products of recom-
bination V(D)J and class switch recombination, and
DNA-PKcs deficiency impairs both of these regulated re-
combination events. Another molecule that may be
involved in both V(D)J and class-switch recombination
is ATM, a component of the cellular network for sensing
DNA damage (reviewed by Canman and Lim 1998).
ATM is mutated in ataxia telangiectasia, an autosomal
recessive disease characterized by loss of cerebellar func-
tions, development of tumors, and deficient T and B cell
responses.
In many recombination/repair processes, genetics has
provided abundant clues to mechanism. However, at
least thus far, the genetic diseases with the most pro-
found impact on switch recombination are caused by
defective cell-cell signaling and intracellular regulation,
rather than by defective recombination; and individuals
with partially impaired somatic hypermutation have
been identified only recently (Levy et al. 1998). Could
class-switch recombination and somatic hypermutation
depend on ubiquitous activities that are essential in other
aspects of DNA metabolism? Could the activities essen-
tial to these processes be backed up by enzymes with
redundant capabilities? Or is it possible that, as more
immunodeficiencies are characterized at the molecular
level, we will come to recognize more genetic diseases
associated with these processes? One purpose of this
review is to invite human geneticists and biochemists
alike to be on the lookout for such defects.
Three Steps to Create and Perfect an Immunoglobulin
Molecule: V(D)J Recombination, Class Switch
Recombination, and Somatic Hypermutation
V(D)J recombination is the site-specific process of re-
combination that occurs in B cells to generate variable
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regions of immunoglobulin molecules or, in T cells, to
create the variable regions of the antigen receptor (re-
viewed by Willerford et al. 1996; Gellert 1997; Schatz
1997). Like other types of recombination, V(D)J recom-
bination can be thought of as comprising sequential
DNA cleavage, synapsis, and religation. The cleavage
reaction is carried out by a pair of proteins, RAG1 and
RAG2, which are produced only in lymphocytes. After
cleavage, nucleotides may be added by terminal trans-
ferase, and the ends are then sealed in a reaction that
depends on ubiquitous factors involved in nonhomo-
logous end joining: Ku70, Ku80, DNA-PKcs, DNA ligase
IV, and XRCC4.
After successful completion of V(D)J recombination,
a newly fledged B cell displays its antigen receptor on
the cell surface and joins the surveillance force of B cells.
Antigen binding activates these cells and initiates the
next phase of their development. Some B cells are stim-
ulated to secrete immunoglobulin immediately, whereas
others proceed along a defined developmental pathway,
in which genomic structure is altered by class-switch
recombination and somatic hypermutation of V regions.
Switch recombination results in the joining of a V(D)J
region to a new downstream C region. Each C-region
class mediates interactions of the immunoglobulin with
specific cellular or soluble factors that allow bound an-
tigens to be cleared from the body.
Somatic hypermutation introduces single base changes
into an expressed V region at a rate nearly a million-
fold higher than the normal mutation rate in mammalian
somatic cells, thereby fine-tuning antigen specificity in a
process that is intimately coupled with selection (for a
collection of recent reviews about this fascinating pro-
cess, see Immunological Reviews Vol. 162, 1998). We
know a great deal about regulation of somatic hyper-
mutation, but essentially nothing about its mechanism.
Nonetheless, in the past year, there has been considerable
progress, both in eliminating genes as potential candi-
dates for function in somatic hypermutation and in iden-
tifying genes that may be involved in hypermutation.
Currently, ∼30 genes—most of them involved in DNA
recombination/repair—have been tested for function in
somatic hypermutation, by analysis of hypermutation
either in strains of mice that carry targeted deletions or
in humans with corresponding genetic disease (reviewed
by Harris et al. 1999). Although we currently know of
no human genetic diseases that result in impaired so-
matic hypermutation, analyses of knock-out mice have
implicated two genes in this process: Pms2 (Cascalho et
al. 1998; Frey et al. 1998; Winter et al. 1998) andMsh2
(Phung et al. 1998; Rada et al. 1998), both components
of the highly conserved eukaryotic mismatch repair sys-
tem. Pms2 appears to affect the hypermutation level,
whereas Msh2 influences the spectrum of mutation. An
intense ongoing controversy surrounds the question of
whether these phenotypes indicate a direct role for mis-
match repair in somatic hypermutation, or if they reflect
altered selective pressures or the effects of chronic stim-
ulation of B cells in the mutant backgrounds. For a taste
of this controversy, see Frey et al. (1998), Kelsoe (1998),
Kim and Storb (1998), and Wiesendanger et al. (1998).
Class Switch Recombination
Class switch recombination is a regulated process of
DNA deletion. After V(D)J recombination, but prior to
switch recombination, the heavy-chain locus is organ-
ized for production of IgM antibodies, in which the
heavy chain contains a V(D)J region just upstream of
the Cm C region (fig. 1). IgM antibodies efficiently re-
move antigen by activating the complement cascade.
Switch recombination results in production of other clas-
ses of antibodies. These include the IgG subclasses, IgG1,
IgG2, IgG3, and IgG4, the major serum antibodies that
remove antigen via their interaction with receptors on
phagocytic cells. IgG antibodies are unique in that they
can cross the placental barrier to provide immune de-
fenses to a newborn baby. IgA antibodies, found in se-
cretions that include saliva, tears, milk, and intestinal
mucus, coat invading pathogens to remove them from
the body. IgE, a very minor class of antibody, sensitizes
mast cells and is associated with allergy. In most people,
the serum antibody distribution is 10% IgM, 75% IgG,
10–15% IgA, and 0.004% IgE. A number of apparently
heritable immunodeficiencies are characterized by al-
tered levels of specific classes or subclasses of serum an-
tibodies; only some of these immunodeficiencies are well
understood.
Class switch recombination involves DNA regions,
called “switch (S) regions,” that are located in the in-
trons upstream of each C region. S regions are 2–10 kb
in length and are composed of repetitive sequences,
which are G rich on the nontemplate strand. Although
the repeats in all the S regions are G rich, the S regions
are not homologous to one another. Of the hundreds of
switch recombination junctions examined, no two are
alike: junctions are heterogeneous in sequence and in the
sites at which both donor (upstream) and acceptor
(downstream) recombination endpoints are located
(Dunnick et al. 1993). Thus, switch recombination does
not depend on site-specific or homologous recombina-
tion processes. It is also important to stress that switch
recombination is completely distinct from V(D)J recom-
bination: it occurs later in B cell development; it rear-
ranges C regions, not variable region segments; it is
region-specific but not sequence-specific; and it is
independent of two proteins essential for V(D)J recom-
bination, RAG1 and RAG2.
In B cells activated for switch recombination, trans-
locations can occur that involve cellular oncogenes. The
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Figure 1 Class switch recombination is a targeted and regulated process of DNA deletion. The top line diagrams the human IgH locus,
showing a rearranged VDJ region, S regions, and C regions. The figure illustrates recombination from m to g1; as a result of this recombination
event, the B cell switches from producing IgM to producing IgG1 antibodies. Recombination is activated by simultaneous transcription of the
Sm and Sg1 regions (arrows). Circular molecules that contain the deleted C region and flanking sequences can be isolated from cells that have
recently carried out switch recombination (middle). This suggests that, during recombination, distant switch regions are brought together to
form a recombination complex, which undergoes cleavage and religation to produce a chromosomal switch junction and the excised switch
circle. Switch recombination junctions are heterogeneous in structure and position, but, since the S regions are found within introns, their
sequences are excluded from the mature immunoglobulin transcripts.
best-studied of these are the translocations of c-myc to
the immunoglobulin heavy-chain loci that are charac-
teristic of certain B cell lymphomas. Switch recombi-
nation may therefore share aspects of mechanism with
aberrant processes of recombination that contribute not
only to cancers but also to development of genetic
disease.
B cells carry out switch recombination in response to
signals from T cells, which stimulate antigen-specific B
cells to initiate a signaling cascade. Essential to this cas-
cade is interaction between the B cell CD40 surface re-
ceptor and the T cell CD40 ligand, CD40L. Genetic
analysis reveals the importance of the CD40/CD40L in-
teraction: mutations in CD40L are responsible for X-
linked hyper-IgM immunodeficiency, characterized by
the absence or extreme decrease in serum IgG and IgA,
but with normal or elevated IgM. Deficient intracellular
signaling is also the cause of X-linked agammaglobuli-
nemia (XLA), an immunodeficiency characterized by the
absence of mature B cells and low levels of all Ig sub-
classes. XLA is caused by lack of Bruton tyrosine kinase
(Btk), an intracellular Src-related nonreceptor tyrosine
kinase. Deficiency of the p85a subunit of phosphoinos-
itide 3-kinase (PI-3 kinase) produces a phenotype inmice
similar to that of Btk deficiency (Fruman et al. 1999).
Simultaneous Transcription of Both Targeted S
Regions Is Prerequisite to Switch Recombination
An important clue to the mechanism of switch recom-
bination is provided by observations from many labo-
ratories showing that switch recombination requires that
both S regions that will carry out recombination be si-
multaneously transcribed (reviewed by Snapper et al.
1997). Each S region carries its own promoter, and tar-
geted deletion of the promoter renders an S region in-
active for recombination. Recombination of specific
switch regions is regulated by a signaling cascade that
is activated when T cell–derived cytokines or lympho-
kines bind to specific receptors on the B cell surface.
Triggering of these receptors is relayed to the nucleus by
a pathway that culminates in binding of transcription
factors to elements in S-region promoters, which results
in activation of S-region transcription. Among the fac-
tors known to regulate switch-region transcription are
members of the JAK/STAT family, NF-IL6, and the p50
subunit of NF-kB (reviewed by Henderson and Calame
1998).
Why is transcription prerequisite to switch recombi-
nation? There are several possible explanations, which
are not mutually exclusive. It is unlikely that the S-region
transcripts encode essential polypeptides, because they
contain many stop codons. Switch transcripts are spliced
after transcription, and the requirement for splicing (Lo-
renz et al. 1995) may reflect involvement of the mature
transcript or the splicing apparatus in switch recombi-
nation. Transcription also alters chromatin structure,
producing a more open conformation, and this may be
necessary to render duplex DNA accessible to enzymes
that carry out recombination (e.g., Willerford et al.
1996). Finally, as is discussed below, transcription may
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cause S-region DNA to assume unusual and character-
istic structures that serve as efficient substrates for a
specific class of recombination enzymes.
Alternative DNA Structures and Class Switch
Recombination
Molecular understanding of how triplet-repeat ex-
pansion contributes to human genetic disease has shown
that DNA has considerable potential to assume struc-
tures distinct from the standard Watson-Crick duplex,
as was recently reviewed in this journal by Sinden
(1999). Analogously, S-region sequences can form al-
ternative DNA structures during transcription in vitro.
When S regions are transcribed, the newly synthesized,
G-rich RNA forms a stable hybrid with the C-rich tem-
plate DNA strand (e.g., Reaban and Griffin 1990), leav-
ing the G-rich DNA strand unpaired and free to form
intra- or interstrand structures that are stabilized by
guanine-guanine (G-G) pairing (e.g., Sen and Gilbert
1988).
Genetic evidence for the potential importance of
G-G–paired DNA in switch recombination comes from
analysis of the human genetic disease, Bloom syndrome.
Bloom syndrome results from mutations in BLM, which
encodes a DNA helicase of the RecQ family. Affected
individuals display a variety of symptoms, including ma-
lignancies, growth retardation, sunlight sensitivity, im-
paired fertility, and immunodeficiency. The BLM heli-
case has ATP-dependent 3′ to 5′ unwinding activity on
duplex DNA substrates (Karow et al. 1997), but it pref-
erentially unwinds G-G paired DNA (Sun et al. 1998),
a property shared by other RecQ family helicases (Sun
et al. 1999). These observations suggest that the failure
to unwind G-G–paired substrates may contribute to the
immunodeficiency that is characteristic of Bloom syn-
drome. Additional evidence for the importance of
G-G–paired DNA in switching comes from analysis of
LR1, a B cell-specific heterodimeric factor. The two sub-
units of LR1, nucleolin and a specific isoform of hnRNP
D, each bind tightly and specifically to standard, B-form
DNA duplex sites in the S regions (Hanakahi et al. 1997;
Dempsey et al. 1998). The LR1 heterodimer and both
its subunits bind with still higher affinity to G-G–paired
DNA, suggesting a working model for switch recom-
bination in which the subunits of LR1 mediate synapsis
by juxtaposing G-G–paired DNA from two different
switch regions (Dempsey et al. 1999).
Other Enzymes that Participate in Class Switch
Recombination
Some of the activities involved in class switch recom-
bination are part of the general repair/recombination
apparatus. Rad51, the eukaryotic homologue of the cru-
cial prokaryotic recombination protein, RecA, is essen-
tial for proliferation of mammalian cells; Rad51 may
also have specific functions in switch recombination (Li
et al. 1996; Peakman and Maizels 1998). The final steps
of the switch-recombination reaction depend on at least
three gene products in the nonhomologous end-joining
pathway for repair of double-strand breaks: DNA-PKcs
(Rolink et al. 1996), Ku70 (Manis et al. 1998), and Ku80
(Casellas et al. 1998). These three proteins also function
in the final stages of V(D)J recombination, along with
DNA ligase IV and XRCC4 (Nussenzweig et al. 1996;
Zhu et al 1996; Frank et al. 1998; Gao et al. 1998;
Grawunder et al. 1998), raising the possibility that the
latter factors are also involved in switch recombination.
Might other proteins that function in general path-
ways of recombination and repair prove to have specific
roles in switch recombination? One candidate is ATM,
a putative protein kinase that is involved in sensingDNA
damage (reviewed by Brown et al. 1999). The ATM
kinase is deficient in ataxia telangiectasia, a genetic dis-
ease characterized by neurodegeneration and telangiec-
tasia, predisposition to cancer, and immunodeficiencies
evident, in part, as variably decreased levels of certain
classes of serum antibodies. As the mechanism and reg-
ulation of switch recombination are worked out in
greater detail, the function of ATM in these pathways
should become apparent.
Recombination requires DNA cleavage, but, despite
considerable interest, no enzyme has yet been identified
that specifically cleaves duplex switch region DNA. In
V(D)J recombination, cleavage is carried out by RAG1
and RAG2. Mutations in RAG1 or RAG2 were only
recently found to result in a previously recognized com-
bined B and T cell immunodeficiency, Omenn syndrome
(Villa et al. 1998). This highlights the possibility that
there may be immunodeficiencies, yet to be defined in
molecular terms, that result from impairment of a cleav-
age activity involved in switch recombination. Alterna-
tively, an enzyme that functions in another context may
be put to use by the switch recombination pathway.
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